Millennium Biotechnologies, Inc. has entered into a five-year exclusive distribution agreement for Resurgex, its nutritional formula for immuno-comprised patients, with Ferring, Inc. of Canada, a division of Ferring S.A.  Under the agreement, Ferring will have the exclusive right to use the Resurgex trademarks and sell the Resurgex line of products in Canada. Ferring will be responsible for the marketing, distribution and sales efforts throughout Canada. Ferring will also purchase all...